Toxocara

From IDWiki
(Redirected from Toxocariasis)
Toxocara


Background

  • Genus of nematode
  • Includes two species of medical importance:
  • Dogs/cats are the definitive hosts, while humans are incidental hosts
    • In humans, the larva are unable to mature into adult worms or to release eggs
  • Distributed worldwide, particularly in low-resource settings with high numbers of feral dog or cat populations
  • About 20% of the global population is seropositive, though there is variation
    • Africa 40%, Southeast Asia 34%, Western Pacific 24%, Americas 23%, Europe 11%, Eastern Mediterranean 8%
  • Risk factors include contact with outdoor dogs and cat, and children

Clinical Manifestations

  • Asymptomatic

Visceral Larva Migrans

  • Most common in children less than 5 years of age
  • Fevers, malaise, weight loss, respiratory symptoms, hepatomegaly, rash, lymphadenopathy
  • Most commonly affects lung and liver, but can also affect cardiac and urinary systems
  • Often see peripheral eosinophilia
  • Pulmonary disease
    • Coughing, wheezing, dyspnea
    • May present as eosinophilic pneumonia or as asthma
  • Liver disease
    • Fevers, abdominal pain, peripheral eosinophila
    • Liver lesions can mimic Fasciola hepatica, bacterial infection, and malignancy
    • Can be complicated by bacterial abscess
  • Cardiac disease

Neurotoxocariasis

  • Invasion of larvae into the CNS
  • Syndromes can include meningoencephalitis, myelitis, spinal abscess, optic neuritis, and cerebral vasculitis
  • May present with epilepsy, cognitive impairment, and behaviour changes

Ocular Toxocariasis

  • Painless (though painful in 30%) unilateral vision loss
  • Photophobia and floaters
  • On ophthalmoscopy, may see vitreitis, posterior of intermediate uveitis, traction retinal detachment, granuloma formation, endophthalmitis, optic neuropathy, and crystoid macular edema
  • Vision loss is usually permanent

Common Toxocariasis

  • Non-specific symptoms in seropositive patients
  • Abdominal pain, anorexia, nausea, vomiting, lethargy, hedaches, myalgias, behaviour change
  • May have eosinophilia

Management

  • Albendazole 400 mg p.o. twice daily for 5 days
  • Alternatively mebendazole, DEC
  • Neoadjuvant corticosteroids should be given be antihelminthic therapy and continued throughout treatment for patients with: cardiac disease, VLM with severe peripheral eosinophilia, ocular infection, neurotoxocariasis
    • Followed by taper